Replies to post #166078 on Biotech Values

[DewDiligence]

Governor Brown vetoes anti-FoB bill:

http://www.nytimes.com/2013/10/13/us/governor-vetoes-bill-to-limit-use-of-generic-drugs-in-california.html

As previously opined in #msg-91738938, I don’t these kinds of state-level bills to make business more onerous for purveyors of FoB will amount to a hill of beans.

[DewDiligence]

Congress seeks explanation for stealth anti-FoB maneuver by FDA:

http://www.pharmalive.com/senators-to-fda-has-biosimliar-naming-policy-changed

I think this FoB-naming issue is no big deal, but other investors think it is, so it’s worth following for that reason.